Position in UTHR
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$118,255,627
+$18,305,549 QoQ
Shares Held
199,426
-2.8% QoQ
Ownership
0.470%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 79.09801129240921.ToString("F0")%
Shared 0.ToString("F0")%
None 20.901988707590785.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Derivatives in UTHR
reported options exposure · as of Dec 31, 2020CallValue
$5,388,545
CallShares
35,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $1,773,009,188 across 50 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,831,652 | $571,149,579 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,958,814 | $119,239,475 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
199,426 | $118,255,627 | |
| 4 | HLN |
Haleon plc
|
10,934,228 | $109,451,619 | |
| 5 | VTRS |
Viatris Inc
|
7,259,555 | $98,076,585 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
4,357,672 | $90,465,268 | |
| 7 | LQDA |
Liquidia Corp
|
2,287,792 | $86,341,267 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
3,358,215 | $80,362,082 |
All Filings in UTHR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $118,255,627 | 199,426 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $99,950,078 | 205,131 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $80,842,129 | 192,844 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $61,126,812 | 212,726 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $73,745,270 | 239,223 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $63,185,526 | 179,077 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $60,142,236 | 167,831 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $58,580,387 | 183,897 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $27,914,652 | 121,516 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $16,080,991 | 73,132 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $20,358,564 | 90,134 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $21,825,108 | 98,868 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $26,361,208 | 117,705 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $29,513,411 | 106,129 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $19,137,329 | 91,400 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $56,747,529 | 240,823 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $46,622,915 | 259,868 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $36,740,512 | 170,032 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $34,138,067 | 184,950 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $24,060,494 | 134,109 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $30,146,399 | 180,226 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $5,388,545 | 35,500 | Call | Defined | 2021-02-10 | |
| 2020-12-31 | $9,072,183 | 59,768 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $15,274,634 | 151,234 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $13,628,109 | 112,629 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $14,899,401 | 157,117 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||